The Clinical Observation About Using Biyuan Heji On Stage Of Mucosal Repairing After Functional Endoscopic Sinus Surgery

Chronic rhinosinusitis(CRS) is a common, frequently-occurring disease in clinical, among which the maxillary sinus incidence of the most common, the ethmoid followed. Common symptoms of chronic rhinosinusitis are nasal obstruction, head chronic dull pain, hyposmia etc. Its incidence is increasing year by year. CRS mainly refers to the nasal cavity-sinus mucosa of chronic inflammatory diseases, the general course of more than three months, divided into polypoid and non-polypoid two. If the nose-sinusitis standardized drug treatment (more than3months) is invalid, especially with polyps, or anatomical structural abnormalities, surgery has become the most effective treatment method. Functional endoscopic sinus surgery (FESS) is currently in clinical practice is the preferred surgical treatment, the main purpose of the surgery is to relieve sinus ostium, the blockage of the nasal passages, unobstructed drainage, morphological and physiological function of the nasal and sinus mucosa recovery, clinical research is to promote epithelialization of the nasal and sinus mucosa. FESS surgical cavity after mucosal edema, recurring polypoid vesicles epithelialization longer, this study will observe the different the application Biyuan mixture after surgical cavity mucosal epithelium by endoscopic demonstration of Chinese medicine in the FESS postoperative involved in the treatment of an important role.Purpose:This study was mainly observed the FESS postoperative surgical cavity clean, the surgical cavity mucous membrane repair time, to demonstrate the important role and clinical significance involved in the treatment of Chinese medicine in the FESS postoperative nasal endoscopy, which in Chinese medicine The FESS postoperative provide the basis for involvement in treatment.Experiment:will meet the standards of the60patients were randomly divided into2groups, plus Biyuan mixture of the test group on the basis of the treatment group, given the same perioperative treatment before surgery,after surgery to anti-infective therapy after discharge respectively intranasal endoscopic surgical cavity mucous membrane of the two groups of patients were observed, and calculate the individual patient’s subjective symptoms, signs and endoscopic mucosal morphology points to observe the differences of the two groups of mucosal repair, the final statistical analysis obtainedconclusions.Results:After the research found that the test group and the control group in the preoperative clinical manifestations, signs and Lund-Kennedy endoscopic mucosal morphology was no significant difference (P greater than0.05); clinical manifestations of the test group before and after surgery, signs and Lund-Kennedy endoscopic mucosal morphology significant difference (P less than0.01); significant difference (P less than0.01) in the control group before and after surgery clinical manifestations, signs and Lund-Kennedy endoscopic mucosal morphology; trial group and control group1week after surgery, clinical manifestations, signs and Lund-Kennedy comparing the difference was not statistically significant (P greater than0.05); experimental group and control group after surgery Jan. clinical presentation, signs, and the difference between the Lund-Kennedy statistically significant (P less than0.01); clinical manifestations of the test group and the control group after surgery in February, signs and Lund-Kennedy comparing the difference was statistically significant (P less than0.01). Test group cure rate of86.7%, the total efficiency of93.3%; control group cure rate of50%, the total efficiency of80%; statistical software in SPSS17, the difference was statistically significance (P less than0.01). FESS the postoperative Biyuan agents involved in the treatment, the patient’s subjective symptoms has been significantly improved, the surgical cavity clean, surgical cavity mucous membrane repair time compared with the control group have obvious advantages, ease FESS mucosal epithelium after timelonger suffering, and the advantages of Chinese medicine treatment of diseases has been embodied, made a useful attempt to participate in the FESS postoperative treatment for Chinese medicine.